EP0948508A4 - Novel coding sequences from herpes simplex virus type-2 - Google Patents

Novel coding sequences from herpes simplex virus type-2

Info

Publication number: EP0948508A4
Authority: EP; European Patent Office
Prior art keywords: coding sequences; herpes simplex; simplex virus; virus type; novel coding
Prior art date: 1996-11-04
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP97946877A

Other languages

German (de)

French (fr)

Other versions

EP0948508A1 (en

Inventor

Klaus Max Esser

John Y Chan

Christine Ell Dabrowski-Amaral

Alfred Michael Delvecchio

Susan B Dillon

Jeffrey Joseph Leary

David Sutton

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

SmithKline Beecham Corp

Original Assignee

SmithKline Beecham Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-11-04

Filing date

1997-10-31

Publication date

2001-11-07

1997-10-31 Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp

1999-10-13 Publication of EP0948508A1 publication Critical patent/EP0948508A1/en

2001-11-07 Publication of EP0948508A4 publication Critical patent/EP0948508A4/en

Status Withdrawn legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
- C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Virology (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Molecular Biology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biotechnology (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Engineering & Computer Science (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Investigating Or Analysing Biological Materials (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

EP97946877A 1996-11-04 1997-10-31 Novel coding sequences from herpes simplex virus type-2 Withdrawn EP0948508A4 (en)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US3027996P	1996-11-04	1996-11-04
US30279P		1996-11-04
US4901897P	1997-06-09	1997-06-09
US49018P		1997-06-09
PCT/US1997/020016 WO1998020016A1 (en)	1996-11-04	1997-10-31	Novel coding sequences from herpes simplex virus type-2

Publications (2)

Publication Number	Publication Date
EP0948508A1 EP0948508A1 (en)	1999-10-13
EP0948508A4 true EP0948508A4 (en)	2001-11-07

Family

ID=26705857

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP97946877A Withdrawn EP0948508A4 (en)	1996-11-04	1997-10-31	Novel coding sequences from herpes simplex virus type-2

Country Status (4)

Country	Link
EP (1)	EP0948508A4 (en)
JP (1)	JP2001508649A (en)
CA (1)	CA2270282A1 (en)
WO (1)	WO1998020016A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2002522451A (en)	1998-08-07	2002-07-23	ユニバーシティオブワシントン	Immunological herpes simplex virus antigens and their use
JP2003512305A (en) *	1999-09-30	2003-04-02	ユニバーシティオブワシントン	Immunologically important herpes simplex virus antigen
US6821519B2 (en) *	2000-06-29	2004-11-23	Corixa Corporation	Compositions and methods for the diagnosis and treatment of herpes simplex virus infection
AU2001273128C1 (en) *	2000-06-29	2006-09-21	Corixa Corporation	Compositions and methods for the diagnosis and treatment of herpes simplex virus infection
AU2002317604A1 (en)	2001-07-31	2003-02-17	Corixa Corporation	Immunologically significant herpes simplex virus antigens and methods for using same
EP2263686B1 (en)	2002-07-18	2012-12-26	University of Washington	Pharmaceutical compositions comprising immunologically active herpes simplex virus (HSV) protein fragments
US8044019B2 (en)	2005-10-28	2011-10-25	Mitsubishi Tanabe Pharma Corporation	Cell penetrating peptide
US8460674B2 (en)	2009-02-07	2013-06-11	University Of Washington	HSV-1 epitopes and methods for using same
WO2010115172A2 (en)	2009-04-03	2010-10-07	University Of Washington	Antigenic peptide of hsv-2 and methods for using same
EP3756684A1 (en)	2009-05-22	2020-12-30	Genocea Biosciences, Inc.	Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
CA2856697A1 (en)	2010-11-24	2012-06-07	Genocea Biosciences, Inc.	Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
CA2885693C (en)	2011-11-23	2020-07-28	Genocea Biosciences, Inc.	Nucleic acid vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
DK2850431T3 (en)	2012-05-16	2018-07-16	Immune Design Corp	Vaccines against HSV-2
CA3002822A1 (en) *	2015-10-22	2017-04-27	Modernatx, Inc.	Herpes simplex virus vaccine
US10350288B2 (en)	2016-09-28	2019-07-16	Genocea Biosciences, Inc.	Methods and compositions for treating herpes
US11752206B2 (en)	2017-03-15	2023-09-12	Modernatx, Inc.	Herpes simplex virus vaccine
EP3641810A4 (en) *	2017-04-26	2021-08-18	Modernatx, Inc.	Herpes simplex virus vaccine
US12070495B2 (en)	2019-03-15	2024-08-27	Modernatx, Inc.	HIV RNA vaccines
EP3999093A4 (en) *	2019-07-19	2023-11-22	Merck Sharp & Dohme LLC	Antigenic glycoprotein e polypeptides, compositions, and methods of use thereof
CN113150071B (en) *	2021-04-25	2023-02-17	上海健康医学院	Marine brevibacillus brevis antitumor active polypeptide and medicine and application thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU7568294A (en) *	1993-08-20	1995-03-21	Smithkline Beecham Corporation	Hsv-2 ul26 gene, capsid proteins, immunoassays and protease inhibitors
GB9325496D0 (en) *	1993-12-14	1994-02-16	Smithkline Beecham Biolog	Vaccines

1997
- 1997-10-31 EP EP97946877A patent/EP0948508A4/en not_active Withdrawn
- 1997-10-31 CA CA002270282A patent/CA2270282A1/en not_active Abandoned
- 1997-10-31 WO PCT/US1997/020016 patent/WO1998020016A1/en not_active Application Discontinuation
- 1997-10-31 JP JP52166998A patent/JP2001508649A/en active Pending

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL ebi; 1 March 1992 (1992-03-01), "HEHS2ULL", XP002172988 *
DATABASE SWALL ebi; 1 March 1989 (1989-03-01), "ul06_HSV11", XP002172987 *
MC GEOCH ET AL: "The complete DNA sequence of the long unique region in the genome of herpes simplex virus type 1", JOURNAL OF GENERAL VIROLOGY,GB,READING, BERKS, vol. Pt 7, no. 69, 1 July 1988 (1988-07-01), pages 1531 - 1574, XP002078443, ISSN: 0022-1317 *
MCGEOCH D J ET AL: "COMPARATIVE SEQUENCE ANALYSIS OF THE LONG REPEAT REGIONS AND ADJOINING PARTS OF THE LONG UNIQUE REGIONS IN THE GENOMES OF HERPESSIMPLEX VIRUSES TYPES 1 AND 2", JOURNAL OF GENERAL VIROLOGY,GB,SOCIETY FOR GENERAL MICROBIOLOGY, READING, vol. 72, no. PART 12, 1 December 1991 (1991-12-01), pages 3057 - 3075, XP000406755, ISSN: 0022-1317 *
See also references of WO9820016A1 *

Also Published As

Publication number	Publication date
WO1998020016A1 (en)	1998-05-14
CA2270282A1 (en)	1998-05-14
JP2001508649A (en)	2001-07-03
EP0948508A1 (en)	1999-10-13

Publication	Publication Date	Title
EP0948508A4 (en)	2001-11-07	Novel coding sequences from herpes simplex virus type-2
EP0928407A4 (en)	2000-11-22	Firearm safety mechanism
IL123683A0 (en)	1998-10-30	Weapon system
GB9620874D0 (en)	1996-11-27	Reflector
GB2300466B (en)	1998-12-16	Recoil counter-vectoring gun
IL114554A (en)	1999-09-22	Ramp-weighted correlation with oversampling
HK1004690A1 (en)	1998-12-04	Light receiving member
AU121868S (en)	1994-10-27	Pistol
GB9415799D0 (en)	1994-09-28	Recoil system
GB2277985B (en)	1997-03-12	Headlamp converters
AU129739S (en)	1997-04-21	Rifle
IL120906A (en)	2003-01-12	Weapon lock
GB2294104B (en)	1997-11-05	Gun case
GB2300247B (en)	1999-09-01	Weapon
GB2310359B (en)	1999-09-15	Improvements ih half-chaps
GB9620381D0 (en)	1996-11-13	Discharge baton
GB9710428D0 (en)	1997-07-16	Breech locking mechanism
GB9620282D0 (en)	1996-11-13	Modified firearm
HU9600124V0 (en)	1996-06-28	Pistol
CA81652S (en)	1997-08-29	Pistol
CA81653S (en)	1997-08-29	Pistol
ZA962565B (en)	1996-12-31	Weapon
GB9523003D0 (en)	1996-01-10	Firearms
TW325131U (en)	1998-01-11	Saluting gun
AU131656S (en)	1997-10-01	Rifle

Legal Events

Date	Code	Title	Description
1999-08-27	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
1999-10-13	17P	Request for examination filed	Effective date: 19990604
1999-10-13	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): BE CH DE DK FR GB IT LI NL
2000-02-02	RAP1	Party data changed (applicant data changed or rights of an application transferred)	Owner name: SMITHKLINE BEECHAM CORPORATION
2001-11-07	A4	Supplementary search report drawn up and despatched	Effective date: 20010924
2001-11-07	AK	Designated contracting states	Kind code of ref document: A4 Designated state(s): BE CH DE DK FR GB IT LI NL
2002-03-08	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN
2002-04-24	18W	Application withdrawn	Withdrawal date: 20020228